Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO.
Saved in:
| Title: | Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. |
|---|---|
| Authors: | Gibiansky E; QuantPharm LLC, MD, USA., Petry C; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Mercier F; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Günther A; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Herman A; Genentech, South San Francisco, CA, USA., Kappos L; University Hospital Basel, Basel, Switzerland., Hauser S; University of California, San Francisco, CA, USA., Yamamoto Y; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Wang Q; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Model F; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Kletzl H; F. Hoffmann-La Roche Innovation Center Basel, Switzerland. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Jun; Vol. 87 (6), pp. 2511-2520. Date of Electronic Publication: 2020 Dec 07. |
| Publication Type: | Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33202059 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gibiansky+E%22">Gibiansky E</searchLink>; QuantPharm LLC, MD, USA.<br /><searchLink fieldCode="AU" term="%22Petry+C%22">Petry C</searchLink>; F. Hoffmann-La Roche Innovation Center Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mercier+F%22">Mercier F</searchLink>; F. Hoffmann-La Roche Innovation Center Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Günther+A%22">Günther A</searchLink>; F. Hoffmann-La Roche Innovation Center Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Herman+A%22">Herman A</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kappos+L%22">Kappos L</searchLink>; University Hospital Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hauser+S%22">Hauser S</searchLink>; University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yamamoto+Y%22">Yamamoto Y</searchLink>; F. Hoffmann-La Roche Innovation Center Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wang+Q%22">Wang Q</searchLink>; F. Hoffmann-La Roche Innovation Center Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Model+F%22">Model F</searchLink>; F. Hoffmann-La Roche Innovation Center Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kletzl+H%22">Kletzl H</searchLink>; F. Hoffmann-La Roche Innovation Center Basel, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2021 Jun; Vol. 87 (6), pp. 2511-2520. <i>Date of Electronic Publication: </i>2020 Dec 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33202059 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bcp.14658 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2511 Titles: – TitleFull: Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gibiansky E – PersonEntity: Name: NameFull: Petry C – PersonEntity: Name: NameFull: Mercier F – PersonEntity: Name: NameFull: Günther A – PersonEntity: Name: NameFull: Herman A – PersonEntity: Name: NameFull: Kappos L – PersonEntity: Name: NameFull: Hauser S – PersonEntity: Name: NameFull: Yamamoto Y – PersonEntity: Name: NameFull: Wang Q – PersonEntity: Name: NameFull: Model F – PersonEntity: Name: NameFull: Kletzl H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2021 Jun Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1365-2125 Numbering: – Type: volume Value: 87 – Type: issue Value: 6 Titles: – TitleFull: British journal of clinical pharmacology Type: main |
| ResultId | 1 |